Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
Substrate reduction therapy for Krabbe's disease.
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases.
Evolution of MRI abnormalities in paediatric acute disseminated encephalomyelitis.
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection.
Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - Commentary.
Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.
Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation.
Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.
Acute Disseminated Encephalomyelitis.
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.
Distinguishing ischaemic optic neuropathy from optic neuritis by ganglion cell analysis.
Global progress in the control of viral hepatitis and acceptable delay in Hepatitis B immunization.
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NFκB.
Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Children and Their Long-Term Follow-Up.
Increasing incidence of multiple sclerosis among women in Buenos Aires: a 22 year health maintenance organization based study.
Rasch analysis of the Fatigue Severity Scale in Italian subjects with multiple sclerosis.
Autoantibody-mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable.
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures.
The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.
Clinical characteristics of disabling attacks at onset in patients with neuromyelitis optica spectrum disorder.
Preferential conduction block of myelinated axons by nitric oxide.
A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.

Pages